Vanessa
Roldan Schilling
Catedraticos de Universidad Vinculados H.V.Arrixaca
![Foto de Vanessa](/img/uploaded/aab593d7615a80d42da1c23d7d2bc16b.jpeg)
![Foto de Aalborg University](/img/noimage_org.png)
Aalborg University
Aalborg, DinamarcaPublicaciones en colaboración con investigadores/as de Aalborg University (46)
2024
2023
-
Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making
American Heart Journal, Vol. 258, pp. 1-16
-
Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review
Science of the Total Environment, Vol. 880
-
Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?
Biomedicine and Pharmacotherapy, Vol. 158
-
The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort
Journal of General Internal Medicine, Vol. 38, Núm. 2, pp. 315-323
2022
-
Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper
Thrombosis and Haemostasis, Vol. 122, Núm. 10, pp. 1625-1652
-
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 24, Núm. 11, pp. 1844-1871
-
Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system
Frontiers in Cardiovascular Medicine
-
Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real-world vs. clinical-trial evidence
British Journal of Clinical Pharmacology, Vol. 88, Núm. 1, pp. 282-289
-
Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry
European heart journal. Cardiovascular pharmacotherapy, Vol. 9, Núm. 1, pp. 38-46
-
Prediction of ischemic stroke in different populations: a comparison of absolute stroke risk and CHA2DS2-VASc in real-world and clinical trial patients
European Journal of Internal Medicine
-
Relation of the ‘Atrial Fibrillation Better Care (ABC) Pathway’ to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists
Journal of Personalized Medicine, Vol. 12, Núm. 3
-
Relationship between temporal rhythm-based classification of atrial fibrillation and stroke: real-world vs. clinical trial
Journal of Thrombosis and Thrombolysis, Vol. 54, Núm. 1, pp. 1-6
2021
-
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Europace, Vol. 23, Núm. 10, pp. 1612-1676
-
Gut microbiota and the quality of oral anticoagulation in vitamin K antagonists users: A review of potential implications
Journal of Clinical Medicine, Vol. 10, Núm. 4, pp. 1-16
-
Outcomes in VKA-treated patients with atrial fibrillation and chronic kidney disease: Clinical trials vs ‘real-world’
International Journal of Clinical Practice, Vol. 75, Núm. 4
-
Prediction of residual stroke risk in anticoagulated patients with atrial fibrillation: mCARS
Journal of Clinical Medicine, Vol. 10, Núm. 15
-
Relationship between multimorbidity and outcomes in atrial fibrillation
Experimental Gerontology, Vol. 153
2020
-
A nurse-led atrial fibrillation clinic: Impact on anticoagulation therapy and clinical outcomes
International Journal of Clinical Practice, Vol. 74, Núm. 12
-
Particulate Matter and Temperature: Increased Risk of Adverse Clinical Outcomes in Patients With Atrial Fibrillation
Mayo Clinic Proceedings, Vol. 95, Núm. 11, pp. 2360-2369